• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2011 Fiscal Year Final Research Report

Novel dendritic cell vaccine for tuberculosis with inhibition of indoleamine 2, 3-dioxygenase.

Research Project

  • PDF
Project/Area Number 21590985
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Respiratory organ internal medicine
Research InstitutionHamamatsu University School of Medicine

Principal Investigator

SUDA Takafumi  浜松医科大学, 医学部, 助教 (30291397)

Co-Investigator(Kenkyū-buntansha) NAKAMURA Yutaro  浜松医科大学, 医学部附属病院, 助教 (60436962)
Co-Investigator(Renkei-kenkyūsha) NAGATA Toshi  浜松医科大学, 医学部, 教授 (90275024)
Project Period (FY) 2009 – 2011
Keywords樹状細胞 / ワクチン / 結核 / 細胞内寄生菌 / indoleamine 2 / 3-dioxygenase(IDO)
Research Abstract

The present study was conducted to develop a novel potent dendritic cell(DC) vaccine by inhibiting indoleamine 2, 3-dioxygenase(IDO) activity for intracellular pathogen infections, such as tuberculosis. We demonstrated that treatment with 1-methyl-L-tryptophan(1MT) decreased IL-10 production from DCs, resulting in augmentation of their antigen-presenting capacity. In addition, we also showed that serum IDO activity is a significant prognostic factor in community-acquired pneumonia and pulmonary tuberculosis.

  • Research Products

    (9 results)

All 2012 2011 2009

All Journal Article (9 results) (of which Peer Reviewed: 9 results)

  • [Journal Article] Serum indoleamine 2, 3-dioxygenase activity predicts prognosis of pulmonary tuberculosis2012

    • Author(s)
      Suzuki Y, Suda T, et al
    • Journal Title

      Clin Vaccine Immunol

      Volume: (in press)

    • Peer Reviewed
  • [Journal Article] Mouse CD11b^<high> lung dendritic cells have more potent capability to induce IgA than CD103^+lung dendritic cells in vitro2012

    • Author(s)
      Suzuki Y, Suda T, Furuhashi K, Shibata K, Hashimoto D, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Nakamura H, Chida K
    • Journal Title

      Am J Respir Cell Mol Biol

      Volume: (in press)

    • Peer Reviewed
  • [Journal Article] Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell(DC) vaccine2012

    • Author(s)
      Kono M, Nakamura Y, Suda T, et al
    • Journal Title

      Vaccine

      Volume: 30 Pages: 2633-2639

    • Peer Reviewed
  • [Journal Article] Serum activity of indoleamine 2, 3-dioxygenase predicts prognosis of community-acquired pneumonia2011

    • Author(s)
      Suzuki Y, Suda T, et al
    • Journal Title

      J Infect

      Volume: 63 Pages: 215-121

    • Peer Reviewed
  • [Journal Article] Mouse lung CD103^+and CD11b^<high> dendritic cells preferentially induce distinct CD4^+T cell responses2011

    • Author(s)
      Furuhashi K, Suda T, et al
    • Journal Title

      Am J Respir Cell Mol Biol

      Volume: 46(2) Pages: 165-172

    • Peer Reviewed
  • [Journal Article] A novel vaccine strategy to induce mycobacterial antigen-specific Th1 responses by utilizing the C-terminal domain of heat shock protein 702011

    • Author(s)
      Uto T, Tsujimura K, Suda T, et al
    • Journal Title

      FEMS Immunol Med Microbiol

      Volume: 61 Pages: 189-196

    • Peer Reviewed
  • [Journal Article] Enhanced anti-tumor immunity by superantigen-pulsed dendritic cells2011

    • Author(s)
      Kato M, Nakamura Y, Suda T, et al
    • Journal Title

      Cancer Immunol Immunother

      Volume: 60 Pages: 1029-1038

    • Peer Reviewed
  • [Journal Article] Expressions of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in lung dendric cells2011

    • Author(s)
      Hasegawa H, Inui N, Suda T, et al
    • Journal Title

      Life Sci

      Volume: 89(7-8) Pages: 282-287

    • Peer Reviewed
  • [Journal Article] Increased serum kynurenine/tryptophan ratio correlates with disease progression in lung cancer2009

    • Author(s)
      Suzuki Y, Suda T, et al
    • Journal Title

      Lung Cancer

      Volume: 67 Pages: 361-365

    • Peer Reviewed

URL: 

Published: 2013-07-31  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi